Terex Corporation files US antitrust claims in insulin case
MLex Summary: Terex Corporation filed a US antitrust complaint accusing Eli Lilly and Co., Novo Nordisk, and Sanofi-Aventis and three pharmacy benefit managers of engaging in a price-fixing scheme concerning insulin.See attached...To view the full article, register now.
Already a subscriber? Click here to view full article